Andrew C. Von Eschenbach
CIK 1536529 · last filed 2026-08-10
Andrew C. Von Eschenbach is a corporate insider who has filed 30 SEC Form 4 insider transactions across 6 companies since 2012. The most recent filing shows the insider sold $306.7K of BLCO on Aug 10, 2026. Across all open-market trades the lifetime net is −$139.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.4M across reported positions. 7 SEC filings were submitted jointly with Bausch Health Companies Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLCO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NJ 08807
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BLCO | Director | 63,733 | $17.36 | $1.11M | -$206.9K | 8 | 2026-08-10 |
| TLSIW | Director | — | $0.75 | — | $0 | 2 | 2024-08-21 |
| Celularity Inc (CELUW) Delisted | Director | 336,066 | $0.00 | $639 | $0 | 5 | 2023-06-16 |
| Radius Health, Inc. (RDUS) Delisted | Director | 0 | $30.00 | $0 | $0 | 3 | 2022-08-15 |
| BHC | Director | 38,647 | $6.33 | $244.4K | $56.3K | 6 | 2021-08-09 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 3,000 | — | — | $11.1K | 3 | 2013-08-14 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-10 | BLCO | Sell (S) | −18,559 | -$306.7K | EDGAR |
| 2026-08-07 | BLCO | Notice (144) | −6,059 | -$100.4K | EDGAR |
| 2026-08-06 | BLCO | Notice (144) | −12,500 | -$206.2K | EDGAR |
| 2026-05-28 | BLCO | Grant (A) | +15,842 | $250.0K | EDGAR |
| 2026-03-03 | BLCO | Mixed | +8,728 | $79.9K | EDGAR |
| 2025-05-28 | BLCO | Grant (A) | +20,338 | $0 | EDGAR |
| 2025-05-06 | BLCO | Buy (P) | +1,695 | $19.9K | EDGAR |
| 2024-08-21 | TLSIW | Grant (A) | — | $0 | EDGAR |
| 2024-08-06 | BLCO | Grant (A) | +14,696 | $0 | EDGAR |
| 2024-06-05 | TLSIW | Gift (G) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.